The aim of the meeting is to analyse the current situation for participating countries in relation to the use of scales to measure the problematic drugs use; also to discuss on the methodology to design evaluation studies; and to designate the group of experts that will design studies and evaluate the working schedule.
The first meeting at an Advisory and Decision taking level of the activity 1.4 took place the 11th and 12th of October 2017 at the city of Santiago, Chile.
The general objective of Activity 1.4 is to produce the methodological designs needed by the NDO of the CELAC countries and other users to have tools to measure problematic drug consumption (general population and adolescents) that will allow generating useful information for decision making.
According to the defined methodology to accomplish the proposed objectives, the Advisory and Decision taking Level had to be established. Its task is to contribute with knowledge on the specific area and take decisions on conceptual and methodological positions as well as select experts and trace the Project evolution. This group is made up of leaders assigned by each country, representatives from EMCDDA, OID-CICAD-OAS and PAHO/WHO, the task-force of the Component, European countries of reference and invited experts when needed
1.5 - Implement a cooperation capacity building strategy in key areas identified, with special focus on the assessment of rising trends of problematic use of specific drugs.
Participants (19 total participants):
3 CELAC countries: Chile, Jamaica, Uruguay
2 EU countries: Cyprus, Romania
COPOLAD Task Force, PAHO, CICAD, EMCDDA
Current situation of participating countries related to the problematic of drug use was analysed as well as the moment where the methodological guidelines for the design of the evaluation studies is. Also was designated the group of experts which will design the studies and finally to evaluate the road map that will be followed furthermore.
Tested and validated, or/and updated evaluation and monitoring tools, processes and tasks, necessary to deepen the knowledge of the drugs situation in CELAC countries.
At least ten (10) NDOs of CELAC countries have participated in the processes of validating tools, and are using them.
Host
EU Reference country (WG)
EU Reference country (WG)
Leader country (WG)
Leader country (WG)
This is a restricted section for participants who attended this activity. Ask for your username and password sending an email to info@copolad.eu
If you already have an username and password, you must log in at My COPOLAD and return to this activity to see the restricted sections.
This is a restricted section for participants who attended this activity. Ask for your username and password sending an email to info@copolad.eu
If you already have an username and password, you must log in at My COPOLAD and return to this activity to see the restricted sections.
This is a restricted section for participants who attended this activity. Ask for your username and password sending an email to info@copolad.eu
If you already have an username and password, you must log in at My COPOLAD and return to this activity to see the restricted sections.
This is a restricted section for participants who attended this activity. Ask for your username and password sending an email to info@copolad.eu
If you already have an username and password, you must log in at My COPOLAD and return to this activity to see the restricted sections.